MolecularHealth Powers Cancer Program For SAP

The Woodlands, Texas-based MolecularHealth, which develops medical decision support technology, said Thursday that it has launched a new program, aimed at employers, and has signed up SAP as one of its first customers. MolecularHealth said its new COPE (Corporate Oncology Program for Employers) is powered by its cancer treatment decision support offering, and gives employees of companies access to its cancer testing and treatment resources. The new offering is targeted at self insured companies. MolecularHealth's tools help generate individual, tumor analysis for patients to help physicians with treatment decisions. Pricing on the new offering, and impact of the customer win, was not announced by MolecularHealth.